Avadel Pharmaceuticals PLC Sponsored ADR Stock

$10.47

1.37% day before yesterday

Nasdaq, Dec 27, 09:46 pm CET

ISIN

US05337M1045

Symbol

AVDL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Avadel Pharmaceuticals PLC Sponsored ADR Stock price

$10.54

+3.26 44.71% 5Y

Nasdaq, Closing price Fri, Dec 27 2024

-0.08 0.71%

ISIN

US05337M1045

Symbol

AVDL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$1.02b
Enterprise Value	$985.74m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	7.13
P/S ratio (TTM) P/S ratio	7.35
P/B ratio (TTM) P/B ratio	13.59
Revenue growth (TTM) Revenue growth	1,523.50%
Revenue (TTM) Revenue	$138.16m
EBIT (operating result TTM) EBIT	$-64.00m
Free Cash Flow (TTM) Free Cash Flow	$-81.98m
Cash position	$65.81m
EPS (TTM) EPS	$-0.77
P/E forward	negative
P/S forward	5.95
EV/Sales forward	5.77
Short interest	12.10%

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Get Started for Free Today

Avadel Pharmaceuticals PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

??

11 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

11x Buy

100%

More details on Analyst Estimates Including Price Targets

11 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Avadel Pharmaceuticals PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	138 138	1,524% 1,524% 100%
- Direct Costs	11 11	343% 343% 8%
Gross Profit	129 129	2,054% 2,054% 93%
- Selling and Administrative Expenses	178 178	45% 45% 129%
- Research and Development Expense	13 13	23% 23% 10%
EBITDA	-62 -62	54% 54% -45%
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	-64 -64	53% 53% -46%
Net Profit	-73 -73	54% 54% -53%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Avadel Pharmaceuticals PLC Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

about 2 months ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

DUBLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET.

Neutral

Seeking Alpha

●

about 2 months ago

Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Austin Murtagh - Director, Precision AQ Greg Divis - CEO Richard Kim - CCO Jennifer Gudeman - SVP, Medical & Clinical Affairs Tom McHugh - CFO Conference Call Participants Andrew Tsai - Jefferies François Brisebois - Oppenheimer Oren Livnat - H.C. Wainwright Ami Fadia - N...

Neutral

GlobeNewsWire

●

about 2 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

DUBLIN, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that yesterday, the U.S. District Court for the District of Columbia (“Court”) ruled in favor of the Food and Drug Administration (“FDA”) in a suit brought by Jazz Pharmaceuticals Inc. (“Jazz”) under the Administrative P...

More Avadel Pharmaceuticals PLC Sponsored ADR News

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Head office	Ireland
CEO	Gregory Divis
Employees	154
Founded	2015
Website	www.avadel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now